Clinical Trial Update: Atezolizumab and BEvacizumab With STereotactic Body Radiotherapy for Advanced Hepatocellular Carcinoma [NA]

View source ↗

Summary

A ClinicalTrials.gov update describes a study of atezolizumab and bevacizumab with stereotactic body radiotherapy for advanced hepatocellular carcinoma, current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Atezolizumab (Tecentriq) (atezolizumab)
• Bevacizumab (Avastin) (bevacizumab)

Snippet

Sponsor: Yonsei University | Conditions: Advanced Hepatocellular Carcinoma, Chemotherapy | NA | Status: RECRUITING